Tirzepatide (Zepbound) is a dual GLP-1 and GIP agonist that helps with weight loss by reducing appetite, slowing digestion, and improving fat metabolism. Clinical trials show up to 22.5% body weight loss, making it one of the most effective obesity treatments available.